What You Should Know:
- While megadeals, trading multiples and overall deal values in the health services sector have not been immune to interest rate hikes and recessionary fears, PwC’s 2023 Health Services Deals Outlook report released recently forecasts a strong year ahead.
- Increasing transaction volumes and players embracing value-based care—coupled with large levels of corporate cash and private equity dry powder—are leading to continued expansion for deal volumes in 2023.
Trends
Read More
Clinical Diagnostics
4th Annual UCSF Health Hub: Digital Health Awards Announced
What You Should Know:
- UCSF Health Hub and the Digital Health Awards team announces the ten Best in Class winning companies, 40 Rising Stars, three Rising Star Champions and two Hall of Fame inductees for the 2022 Digital Health Awards.
- The winning companies were chosen from more than 1,200 submissions based on a rigorous judging criteria. In the first round of judging, the priority was on reviewing every aspect of
Read More
BrightInsight & bioMérieux Partner to Develop Clinical Digital Solution for Diagnostics
What You Should Know:
- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions and bioMérieux, a world leader in the field of in vitro diagnostics, announced today a partnership to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests.
- bioMérieux will launch a digital solution for diagnostics leveraging the compliant
Read More
Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists
What You Should Know:
- Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology artificial intelligence (AI) software with world-class industry experts in the development of AI algorithms to provide precision and speed in clinical pathology.
- Together, Tribun Health and Mindpeak help pathologists analyze whole-slide-images (WSI) of immunohistochemically (IHC) stained human
Read More
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis.
As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
Kaiser Appoints First Chief Digital Officer, Teladoc’s New COO, Castlight Health CEO, Other Health IT Appointments
Kaiser Permanente has appointed Prat Vemana as its first chief digital officer for Kaiser Foundation Health Plan and Hospitals. In this newly created role, Vemana will lead the ongoing development and execution of Kaiser Permanente's digital vision and strategy, in collaboration with internal health plan, hospital, and medical group teams.
Atlantic Health System has named Dr. Sylvia Romm as Chief Innovation Officer. In her new role, Romm will be responsible for building new partner
Read More
FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
1DROP Raises $4.25M to Support Commercialization of Portable Medical Diagnostics Platform
1DROP, a life sciences startup developing and commercializing an easy to use laboratory quality, portable medical diagnostic testing platform has raised $4.25 million in Series A funding led by led by Christian Wildmoser (former partner CVC Capital Partners & Swiss Startup Group Investor). The round also included participation from private investors of the Swiss Startup Group including Dr. Hans-Peter Strebel (owner of On Your Marks), Beat Schillig (IFJ Institute for Young Entrepreneurs) and
Read More
Mount Sinai Spinout Sema4 Launches to Revolutionize Clinical Diagnostics
Sema4, a new startup that has spun out of Mount Sinai Health System has officially launched today that aims to use genomic and clinical data to empower more informed health decisions and enhance care and wellness. Formerly the Mount Sinai Genetic Testing Lab at the Icahn School of Medicine at Mount Sinai, Sema4 is constructing a more comprehensive picture of health by combining a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class
Read More
